Magnetic resonance imaging for diagnosis of acute pulmonary embolism: not yet a suitable alternative to CT-PA
Diagnostic accuracy of magnetic resonance imaging for an acute pulmonary embolism: results of the ‘IRM-EP’ study
Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism
Pulmonary embolism in sickle cell disease: a case–control study
An evaluation of gene–gene interaction between the CYP2C9 and VKORC1 genotypes affecting the anticoagulant effect of phenprocoumon and acenocoumarol
Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the recombinant factor VIIa variant BAY 86-6150 in hemophilia
Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A
Complement activation in thrombotic thrombocytopenic purpura
A lower starting dose of eltrombopag is efficacious in Japanese patients with previously treated chronic immune thrombocytopenia
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer
Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case-control study
Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEE
A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis
Prevalence and predictors for post-thrombotic syndrome 3 to 16 years after pregnancy-related venous thrombosis: a population-based, cross-sectional, case-control study
Plasma factor VII-activating protease antigen levels and activity are increased in ischemic stroke
Factor seven-activating protease: does it do what it says on the tin?
Factor seven activating protease (FSAP): does it activate factor VII?
A Protease TAMER: a nucleic acid-based anticoagulant
A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity
The PAI-1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women
Identification of tristetraprolin as a factor that modulates the stability of the TAFI transcript through binding to the 3′-untranslated region
Procoagulant and prothrombotic effects of the herbal medicine, Dipsacus asper and its active ingredient, dipsacus saponin C, on human platelets
The genomic and proteomic blueprint of mouse megakaryocytes derived from embryonic stem cells
Invisible vesicles swarm within the iceberg
Single vs. swarm detection of microparticles and exosomes by flow cytometry
A new approach for rapid and reliable enumeration of circulating endothelial cells in patients
Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W
Reduced von Willebrand factor secretion is associated with loss of Weibel–Palade body formation
Standardization of von Willebrand factor propeptide: value assignment to the WHO 6th IS Factor VIII/von Willebrand factor, plasma (07/316)
Diagnostic accuracy of computed tomography pulmonary angiography and magnetic resonance imaging for an acute pulmonary embolism
Family history of venous thromboembolism is associated with increased risk for thrombosis in multiple myeloma: a population-based study
Plasma levels of Midkine (neurite growth-promoting factor 2) are not associated with plasma fibrinolytic potential or risk of venous thrombosis
Dabigatran efficacy-safety assessment for stroke prevention in patients with atrial fibrillation
Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study
Influence of endothelial cell protein C receptor on plasma clearance of factor VIIa
Vascular endothelial growth factor, as compared with placental growth factor, is increased in severe sepsis but not in organ failure